These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35243952)

  • 1. Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data.
    Gauthier-Loiselle M; Tsang Y; Lefebvre P; Agron P; Royer J; Bell Lynum KS; Bennett L; Panjabi S
    Curr Med Res Opin; 2022 Jun; 38(6):1019-1030. PubMed ID: 35243952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension.
    Zhang C; Tsang Y; He J; Panjabi S
    Adv Ther; 2023 May; 40(5):2481-2492. PubMed ID: 37024760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis.
    Sargent T; Tsang Y; Panjabi S; Funtanilla V; Germack HD; Gauthier-Loiselle M; Manceur AM; Cloutier M; Lefebvre P
    Adv Ther; 2023 Nov; 40(11):5037-5054. PubMed ID: 37728697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of selexipag use within 12 months of pulmonary arterial hypertension diagnosis on hospitalizations and medical costs: A retrospective cohort study.
    Tsang Y; Stokes M; Kim YJ; Tilney R; Panjabi S
    Clin Respir J; 2023 Dec; 17(12):1209-1222. PubMed ID: 37804160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of right heart catheterization in patients initiated on pulmonary arterial hypertension therapies: A population-based study.
    Duarte AG; Lin YL; Sharma G
    J Heart Lung Transplant; 2017 Feb; 36(2):220-226. PubMed ID: 27595194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
    Copher R; Cerulli A; Watkins A; Laura Monsalvo M
    J Med Econ; 2012; 15(5):947-55. PubMed ID: 22554140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE.
    Muller A; Escribano-Subias P; Fernandes CC; Fontana M; Lange TJ; Söderberg S; Gaine S
    Adv Ther; 2024 Mar; 41(3):1103-1119. PubMed ID: 38216826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.
    Kirson NY; Birnbaum HG; Ivanova JI; Waldman T; Joish V; Williamson T
    Appl Health Econ Health Policy; 2011 Sep; 9(5):293-303. PubMed ID: 21875160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 10. A claims-based, machine-learning algorithm to identify patients with pulmonary arterial hypertension.
    Hyde B; Paoli CJ; Panjabi S; Bettencourt KC; Bell Lynum KS; Selej M
    Pulm Circ; 2023 Apr; 13(2):e12237. PubMed ID: 37287599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study.
    Berger A; Edelsberg J; Teal S; Mychaskiw MA; Oster G
    BMC Pulm Med; 2012 Dec; 12():75. PubMed ID: 23231890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A machine learning approach to identifying patients with pulmonary hypertension using real-world electronic health records.
    Kogan E; Didden EM; Lee E; Nnewihe A; Stamatiadis D; Mataraso S; Quinn D; Rosenberg D; Chehoud C; Bridges C
    Int J Cardiol; 2023 Mar; 374():95-99. PubMed ID: 36528138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updated treatment algorithm of pulmonary arterial hypertension.
    Galiè N; Corris PA; Frost A; Girgis RE; Granton J; Jing ZC; Klepetko W; McGoon MD; McLaughlin VV; Preston IR; Rubin LJ; Sandoval J; Seeger W; Keogh A
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D60-72. PubMed ID: 24355643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.
    Weiss TJ; Rosen Ramey D; Yang L; Liu X; Patel MJ; Rajpathak S; Bajwa EK; Lautsch D
    BMC Pulm Med; 2022 Oct; 22(1):383. PubMed ID: 36258171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
    Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
    J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.
    Burke JP; Hunsche E; Régulier E; Nagao M; Buzinec P; Drake Iii W
    Am J Manag Care; 2015 Jan; 21(3 Suppl):s47-58. PubMed ID: 25734573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of atrial septostomy and effect on long-term survival in patients with idiopathic pulmonary arterial hypertension: A single-center cohort.
    Xing C; Wang X; Pan X; Yu J; Wang C; Li Y; Shen L; He B
    Int J Cardiol; 2023 Feb; 373():118-123. PubMed ID: 36476671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospitalization Among Pulmonary Arterial Hypertension Patients With and Without Connective Tissue Disease Comorbidities Prescribed Oral Selexipag.
    Tsang Y; Singh R; Verma S; Panjabi S
    Rheumatol Ther; 2023 Jun; 10(3):741-756. PubMed ID: 36959524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.
    Sonnweber T; Tymoszuk P; Steringer-Mascherbauer R; Sigmund E; Porod-Schneiderbauer S; Kohlbacher L; Theurl I; Lang I; Weiss G; Löffler-Ragg J
    BMC Pulm Med; 2023 Apr; 23(1):143. PubMed ID: 37098543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
    Xu ZY; Zhang HS; Li QQ; Zhang C; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Mar; 50(3):282-288. PubMed ID: 35340148
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.